ArticleOncology reports2017

Upregulation of MUC1 by its novel activator 14-3-3ζ promotes tumor invasion and indicates poor prognosis in lung adenocarcinoma.

Min Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.